Core Viewpoint - Kymera Therapeutics, Inc. has announced a public offering of $250.8 million in common stock and pre-funded warrants to advance its pipeline of oral small molecule degrader medicines for immunological diseases [1][2]. Group 1: Offering Details - Kymera is selling 5,044,500 shares of common stock at a price of $44.00 per share and pre-funded warrants to purchase 655,500 shares at $43.9999 each [1]. - The gross proceeds from the offering are expected to be approximately $250.8 million, before deducting underwriting discounts and commissions [1]. - The underwriters have a 30-day option to purchase up to an additional 855,000 shares at the public offering price [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be used to advance Kymera's pipeline of preclinical and clinical degrader programs, as well as for working capital and other general corporate purposes [2]. Group 3: Company Background - Kymera Therapeutics is a clinical-stage biotechnology company focused on targeted protein degradation (TPD) to develop innovative medicines for significant health issues [6]. - The company aims to provide a new generation of effective therapies for patients with immunological diseases [6].

Core Viewpoint - Wuxi Lichi Intelligent Equipment Co., Ltd. has submitted an application for an IPO on the Shenzhen Stock Exchange's Growth Enterprise Market, aiming to raise 1.008 billion yuan for projects including an intelligent manufacturing base for material automation processing equipment and a research and development center [1][13]. Company Overview - Lichi Intelligent focuses on automated material processing, providing comprehensive solutions for material intelligent processing systems, with applications in lithium battery manufacturing, fine chemicals, and composite materials [3]. - Established in April 2018, the company has a registered capital of approximately 367 million yuan, with major shareholders including Ningbo Zhilian Enterprise Management Partnership and Chen Haodong [3]. Financial Performance - Revenue for Lichi Intelligent was approximately 619 million yuan in 2022, projected to reach 1.721 billion yuan in 2023 and 2.173 billion yuan in 2024, reflecting a compound annual growth rate of 87.4% [5]. - Net profit figures were around 95.35 million yuan in 2022, increasing to 242 million yuan in 2023 and 299 million yuan in 2024 [5]. Revenue Breakdown - The majority of revenue comes from the material intelligent processing system, with sales of approximately 393 million yuan, 877 million yuan, and 1.656 billion yuan for the years 2022, 2023, and 2024, respectively [6]. - Revenue from the lithium battery manufacturing sector accounted for 95.98%, 91.81%, and 93.82% of total revenue in the same years [7]. Customer Concentration - Lichi Intelligent has a high customer concentration, with the top five customers contributing 86.87%, 81.67%, and 74.27% of total revenue in 2022, 2023, and 2024, respectively [7]. - Major clients include CATL, BYD, LG Energy Solution, and others, with significant fluctuations in sales to these customers over the years [8][9]. Use of Proceeds - The company plans to allocate 609 million yuan for the intelligent manufacturing base project, 199 million yuan for the R&D center, and 200 million yuan for working capital from the IPO proceeds [13][14]. Financial Ratios - The company's asset-liability ratio was approximately 86.78%, 82.43%, and 76.48% for the years 2022, 2023, and 2024, respectively, indicating a decreasing trend [14][15]. - As of the end of 2024, total liabilities were approximately 3.574 billion yuan [15].

立法僵局背后折射出更复杂的博弈：参议院版本法案在众议院面临不确定性，加密行业内部逐渐形成共 识，认为将稳定币法案与更具争议的市场结构立法打包通过，可能借助前者积蓄的立法势能突破后者困 境。参议院法案发起人比尔·哈格蒂、汤姆·蒂利斯等参议员已多次呼吁众议院直接采纳参议院版本，避 免另起炉灶延误时机。 当前立法时间表呈现双线并进态势：参议院银行委员会主席蒂姆·斯科特承诺9月底前将市场结构法案移 出委员会审议，而农业委员会也可能介入审议流程，这为法案通过增添变数。众议院共和党助理透露， 领导层仍在权衡最优推进方案，既要满足白宫对效率的要求，又需平衡党内不同派系对监管尺度的分 歧。这场围绕数字货币监管框架的立法博弈，正进入最终冲刺阶段。 智通财经APP获悉，美国众议院正酝酿以特殊程序推动加密货币立法进程，知情人士透露其计划将稳定 币监管法案《天才法案》与加密货币市场结构法案《澄清法案》捆绑审议，最早或于7月7日当周提交全 体表决。这一策略调整旨在通过单次程序性投票同时推进两项法案，相关立法细节仍处于保密磋商阶 段。 作为立法核心的《天才法案》聚焦稳定币监管标准化，参议院本月已以两党跨派系支持通过该法案。特 朗普总统随 ...

编者按 活力中国看广东。我们相信，以"再造一个新广东"为目标，广东能够行稳致远，在更多领域从全国第一 迈向世界前列。 在此次调研采访启动之际，记者通过多方渠道深挖广东究竟有多少"全国第一"。 广东省《政府工作报告》提到九个"全国首位""全国第一"。除了地区生产总值居全国第一外，进出口总 额突破9万亿元、增长9.8%，总量连续39年居全国首位；地方一般公共预算收入1.35万亿元，连续34年 居全国首位；经营主体净增98万户、突破1900万户，其中企业超830万户，总量均居全国第一；全省研 发经费支出突破5100亿元、研发投入强度3.6%，高新技术企业7.7万家，区域创新能力连续8年全国第 一；广东海上风电并网容量超1200万千瓦，跃居全国首位；广东推进大湾区国家技术创新中心建设，布 局建设7个省中试平台，高价值发明专利拥有量、PCT国际专利申请量等稳居全国首位；在2024年巴黎 奥运会上，获8金4银4铜，金牌数奖牌数均居全国首位；广东发展普惠托育服务，托育服务机构和可提 供托位数量均居全国首位。 在"活力中国调研行"广东站启动会上，广东省教育厅、工信厅、科技厅、发展改革委、金融办、人才局 有关负责人介绍了相关情 ...

总有一群年轻人在庆祝"再也不用经历开学"这件事。 但相比十年前的毕业季， "找工作"中的忐忑， 已渐渐遮盖对"过上自己想要的生活"的向往。 自创立以来，《职场Bonus》能看到就业市场的诸多风口中，唯有两个趋势长久不变：「AI」和「出海」。 前者抬高行业下限，后者拓宽商业疆域。 关于AI，我们今年已分别在北京、深圳举办了《用AI造福你我的职业》、《在AI下半场成为核心人才》两场人才沙龙。 36氪「职场Bonus」（ID：ZhiChangHongLi） 36氪「职场Bonus」（ID：ZhiChangHongLi） 而在出海圈，我们发现一些院校和专业的人才尤其受雇主欢迎，也走出了不少履历从平凡到闪耀的校友。 我们一直相信一句话： 阅历故事能鼓舞人心，打破常规的人脉链接能改变命运。 7月6日，《职场Bonus》将围绕「出海」红利主题，瞄准出海领域最受欢迎的高校群，搭建一个校友、雇主企业共同参与的职场社交聚会。让优质院校的精 英校友们一起来答你的心中之问。 7.06 11 36K, 肥场红利 > 图层 H XS : 週 把握行业先机 我们将邀请行业内的先锋人物、企业高管和创始人亲临到 场。他们站在出海领域的前沿,洞 ...

首先，从昨夜外围市场行情来看，整体表现较好，美股三大指数全线上涨，纳斯达克指数上涨0.97%， 道琼斯指数上涨0.94%，标普指数上涨0.8%。其中纳指很快将接近历史最高点，那么今晚是否会形成历 史最高点的突破呢？彭根认为这种概率很大，昨天纳指顶着三条压力线的压制，仍然成功突破了其中两 条压力线，今晚很有可能会直接冲破压力线，迎来新高。 （原标题：投顾观市：外围市场全线上涨，今天A股能收阳吗？） 6月27日，投顾彭根在今日市场分析中指出，市场中有一句经典的话叫做"横有多长，竖有多高。"目 前，A股在经历了924行情之后，已经横盘了8个多月。这样长时间的大周期横盘，如今终于形成了关键 性的突破。经过6个多月的震荡整理，市场在6月27日成功突破了去年12月31日形成的高点3,418点。这 句"横有多长，竖有多高"所表达的意思是，经过长时间的大周期横盘震荡整理之后，一旦形成关键性的 突破，可能会引发一场超级行情。 此外，彭根注意到日经指数也呈现出上升三角形的形态，并且已经形成了突破，也存在大波段上行的可 能性。对于港股的判断，恒生指数前期大幅拉升，在面临前期高点时，进行了A、B、C三浪的震荡整 理，而目前所走的波段 ...

智通财经6月27日电，据贵州省纪委监委消息：贵州省贵阳市委常委、市委宣传部部长黄成虹涉嫌严重 违纪违法，目前正接受贵州省纪委监委纪律审查和监察调查。 贵州省贵阳市委常委黄成虹接受审查调查 ...

Core Viewpoint - The share transfer plan of Huace Testing involves the transfer of up to 17.26 million shares to the actual controller's action group, which will not change the total shareholding of the actual controller and its concerted actors, maintaining a 22.06% stake in the company [1][2]. Group 1: Share Transfer Details - The transfer will occur through block trading and will not exceed 1.031% of the company's total share capital after excluding repurchased shares [1]. - The transfer period is set from July 21, 2025, to October 20, 2025, with trading prices determined by the secondary market [1]. - After the transfer, the actual controller's total shareholding will remain unchanged at 371,183,884 shares [1][2]. Group 2: Financial Performance - Huace Testing's revenue for 2022, 2023, and 2024 is reported as 5.13 billion, 5.60 billion, and 6.08 billion yuan respectively, showing an increase of 8.55% from 2023 to 2024 [2][3]. - The net profit attributable to shareholders for the same years is 9.03 billion, 9.10 billion, and 9.21 billion yuan, indicating a slight increase of 1.19% from 2023 to 2024 [2][3]. - The cash flow from operating activities for 2022, 2023, and 2024 is reported as 11.00 billion, 11.22 billion, and 10.63 billion yuan, with a decrease in 2024 [2][3]. Group 3: Recent Quarterly Performance - In Q1 2025, the company reported a revenue of 1.29 billion yuan, a year-on-year increase of 7.96% [4][5]. - The net profit attributable to shareholders for Q1 2025 is 136.19 million yuan, reflecting a 2.75% increase compared to the same period last year [4][5]. - The net cash flow from operating activities for Q1 2025 is reported at -89.94 million yuan, showing a significant improvement of 47.10% year-on-year [4][5].

中新网沈阳6月27日电(李晛)辽宁省侨联26日在沈阳举行"创业中华 侨兴辽宁"共建"一带一路"赋能侨企 出海交流活动。 6月26日，"创业中华 侨兴辽宁"共建"一带一路"赋能侨企出海交流活动在沈阳举行。(辽宁省侨联供图) 交流活动中，中国经济改革研究基金会理事长石明磊作了主旨分享，针对侨企出海面临的国际环境、政 策支持、风险挑战，以及多部门联动服务、海外园区要素等做了解读，建议用好各类服务平台，积极开 展以侨架桥、以侨招商、以侨引智，进一步提升辽宁侨企"出海"的知名度和影响力。 辽宁天久企业集团、辽宁杏林整形外科医院集团有限公司等10家侨企负责人分享了智能制造、生物医 药、现代农业等多个项目的发展情况，表示将积极参与"一带一路"建设，为辽宁坚决打好打赢决胜之年 决胜之战贡献侨界力量。 活动由辽宁省侨联党组书记、主席安建晔主持。他在介绍辽宁侨情时说，辽宁侨务资源丰富，辽宁籍华 侨华人海外分布较广、受教育程度较高、从事工作领域较宽、新华侨华人数量比例较大。辽宁省侨联以 深度融入共建"一带一路"作为推动辽宁全面振兴新突破的关键抓手，发挥桥梁纽带作用，持续深化"侨 助千企万品出海"行动，重点在政策对接、市场开拓、人才 ...

Group 1 - The controlling shareholder, Niuwei Group, plans to reduce its stake in Niuwei Co., Ltd. by up to 7,490,620 shares, representing 0.97% of the total share capital, through centralized bidding within three months after the announcement [1][2] - The implementation of the share reduction plan is subject to market conditions and the company's stock price, indicating uncertainty in the timing and pricing of the reduction [2] - Niuwei Co., Ltd. reported a revenue of 6.238 billion yuan in 2024, a year-on-year increase of 12.50%, and a net profit attributable to shareholders of 1.156 billion yuan, reflecting a significant growth of 60.10% [3][4] Group 2 - The company achieved a net cash flow from operating activities of 1.112 billion yuan in 2024, marking a 74.50% increase compared to the previous year [3][4] - In the first quarter of 2025, Niuwei Co., Ltd. reported a revenue of 1.556 billion yuan, a year-on-year growth of 14.44%, and a net profit of 263 million yuan, up 33.52% [5][6] - The company plans to distribute a cash dividend of 1.14 yuan per share, totaling approximately 876 million yuan, based on a total share capital of 768,573,661 shares [4]